ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-5E14455
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Newcastle Disease Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Research Report 2023
BUY CHAPTERS

Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Research Report 2025

Code: QYRE-Auto-5E14455
Report
January 2025
Pages:70
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Boehringer Ingelheim
Pulike
Luoyang Huizhong Biotechnology Co., Ltd.

Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market

The global market for Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Chicken embryos were inoculated with chicken embryos mixed with chicken newcastle virus ii strains and chicken pox virus weak strains, chicken infectious bronchitis virus H120 strains were inoculated with chicken embryos alone, chicken embryo solution and villurionic allantouria membrane were harvested, homogenized in a certain proportion, stabilizer was added, and dried by freezing vacuum.
Global demand for poultry products such as chicken and eggs continues to grow owing to factors such as population growth, increasing disposable income, and changing dietary preferences. This increased demand requires healthier and more efficient poultry farming methods, including vaccinations to prevent disease.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine.
The Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Box) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Report

Report Metric Details
Report Name Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market
Segment by Type
  • Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Live
  • Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Inactivated
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim, Pulike, Luoyang Huizhong Biotechnology Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market report?

Ans: The main players in the Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market are Boehringer Ingelheim, Pulike, Luoyang Huizhong Biotechnology Co., Ltd.

What are the Application segmentation covered in the Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market report?

Ans: The Applications covered in the Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market report are Veterinary Drug, Scientific Research

What are the Type segmentation covered in the Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market report?

Ans: The Types covered in the Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market report are Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Live, Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Inactivated

Recommended Reports

Poultry Disease Vaccines

Animal Viral Vaccines

Livestock and Aquaculture

1 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Overview
1.1 Product Definition
1.2 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine by Type
1.2.1 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Live
1.2.3 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Inactivated
1.3 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine by Application
1.3.1 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Veterinary Drug
1.3.3 Scientific Research
1.4 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size Estimates and Forecasts
1.4.1 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue 2020-2031
1.4.2 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales 2020-2031
1.4.3 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Competition by Manufacturers
2.1 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Date of Enter into This Industry
2.8 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Competitive Situation and Trends
2.8.1 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Players Market Share by Revenue
2.8.3 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Scenario by Region
3.1 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Region: 2020-2031
3.2.1 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Region: 2020-2025
3.2.2 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Region: 2026-2031
3.3 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Region: 2020-2031
3.3.1 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Region: 2020-2025
3.3.2 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Region: 2026-2031
3.4 North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Facts & Figures by Country
3.4.1 North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2020-2031)
3.4.3 North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Facts & Figures by Country
3.5.1 Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2020-2031)
3.5.3 Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Facts & Figures by Country
3.7.1 Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Type (2020-2031)
4.1.1 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Type (2020-2025)
4.1.2 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Type (2026-2031)
4.1.3 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Type (2020-2031)
4.2.1 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Type (2020-2025)
4.2.2 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Type (2026-2031)
4.2.3 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Application (2020-2031)
5.1.1 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Application (2020-2025)
5.1.2 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Application (2026-2031)
5.1.3 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Application (2020-2031)
5.2.1 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Application (2020-2025)
5.2.2 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Application (2026-2031)
5.2.3 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Company Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boehringer Ingelheim Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Pulike
6.2.1 Pulike Company Information
6.2.2 Pulike Description and Business Overview
6.2.3 Pulike Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pulike Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Product Portfolio
6.2.5 Pulike Recent Developments/Updates
6.3 Luoyang Huizhong Biotechnology Co., Ltd.
6.3.1 Luoyang Huizhong Biotechnology Co., Ltd. Company Information
6.3.2 Luoyang Huizhong Biotechnology Co., Ltd. Description and Business Overview
6.3.3 Luoyang Huizhong Biotechnology Co., Ltd. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Luoyang Huizhong Biotechnology Co., Ltd. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Product Portfolio
6.3.5 Luoyang Huizhong Biotechnology Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Industry Chain Analysis
7.2 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Mode & Process Analysis
7.4 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales and Marketing
7.4.1 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Channels
7.4.2 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Distributors
7.5 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Customer Analysis
8 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Dynamics
8.1 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Industry Trends
8.2 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Drivers
8.3 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Challenges
8.4 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Boehringer Ingelheim
Pulike
Luoyang Huizhong Biotechnology Co., Ltd.
List of Tables
 Table 1. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales (Box) of Key Manufacturers (2020-2025)
 Table 5. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Average Price (US$/Box) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Region (2020-2025) & (Box)
 Table 18. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Region (2026-2031) & (Box)
 Table 20. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2020-2025) & (Box)
 Table 27. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2026-2031) & (Box)
 Table 28. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2020-2025) & (Box)
 Table 32. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2026-2031) & (Box)
 Table 33. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Region (2020-2025) & (Box)
 Table 37. Asia Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Region (2026-2031) & (Box)
 Table 38. Asia Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2020-2025) & (Box)
 Table 42. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2026-2031) & (Box)
 Table 43. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2020-2025) & (Box)
 Table 47. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales by Country (2026-2031) & (Box)
 Table 48. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales (Box) by Type (2020-2025)
 Table 51. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales (Box) by Type (2026-2031)
 Table 52. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Price (US$/Box) by Type (2020-2025)
 Table 59. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Price (US$/Box) by Type (2026-2031)
 Table 60. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales (Box) by Application (2020-2025)
 Table 61. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales (Box) by Application (2026-2031)
 Table 62. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Price (US$/Box) by Application (2020-2025)
 Table 69. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Price (US$/Box) by Application (2026-2031)
 Table 70. Boehringer Ingelheim Company Information
 Table 71. Boehringer Ingelheim Description and Business Overview
 Table 72. Boehringer Ingelheim Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 73. Boehringer Ingelheim Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Product
 Table 74. Boehringer Ingelheim Recent Developments/Updates
 Table 75. Pulike Company Information
 Table 76. Pulike Description and Business Overview
 Table 77. Pulike Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 78. Pulike Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Product
 Table 79. Pulike Recent Developments/Updates
 Table 80. Luoyang Huizhong Biotechnology Co., Ltd. Company Information
 Table 81. Luoyang Huizhong Biotechnology Co., Ltd. Description and Business Overview
 Table 82. Luoyang Huizhong Biotechnology Co., Ltd. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 83. Luoyang Huizhong Biotechnology Co., Ltd. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Product
 Table 84. Luoyang Huizhong Biotechnology Co., Ltd. Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Distributors List
 Table 88. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Customers List
 Table 89. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Trends
 Table 90. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Drivers
 Table 91. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Challenges
 Table 92. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine
 Figure 2. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Live Product Picture
 Figure 5. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Inactivated Product Picture
 Figure 6. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Veterinary Drug
 Figure 9. Scientific Research
 Figure 10. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales (2020-2031) & (Box)
 Figure 13. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Average Price (US$/Box) & (2020-2031)
 Figure 14. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Report Years Considered
 Figure 15. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Share by Manufacturers in 2024
 Figure 16. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Players: Market Share by Revenue in Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine in 2024
 Figure 18. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share by Country (2020-2031)
 Figure 21. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Market Share by Country (2020-2031)
 Figure 22. United States Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Market Share by Region (2020-2031)
 Figure 33. China Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine by Type (2020-2031)
 Figure 54. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Price (US$/Box) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine by Application (2020-2031)
 Figure 57. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Price (US$/Box) by Application (2020-2031)
 Figure 58. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Infectious Bursal Disease Vaccine Market Research Report 2024
Global Poultry Bacterial Disease Vaccines Market Research Report 2024
Global Newcastle Disease Vaccine Market Research Report 2025
Global Chicken Newcastle Disease Vaccine Market Research Report 2024
Global Poultry Viral Disease Vaccines Market Research Report 2024
Global Vaccine Against Infectious Coryza for Poultry Market Research Report 2024
Global Inactivated Poultry Vaccines Market Research Report 2024
Global Poultry Liquid Vaccine Market Research Report 2024
Global Genetically Engineered Vaccines for Poultry Market Research Report 2024
Global Newcastle Disease Treatment Market Research Report 2024
Global Norovirus Vaccine Market Research Report 2024
Global Swine Parvovirus Disease Vaccine Market Research Report 2024
Global Vaccines for the Elderly Market Research Report 2024
Global Poultry Genetic Engineering Vaccine Market Research Report 2024
Global Mareks Vaccine for Poultry Market Research Report 2025
Global Chicken Infectious Bronchitis Virus IgG Antibody Detection Kit Market Research Report 2024
Global Porcine Circovirus Diseases Vaccine Market Research Report 2024
Global 1Type 1 Hib Vaccine Market Research Report 2024
Global Animal Parvovirus Vaccine Market Research Report 2024
Global Consumption Type Vaccine Market Research Report 2024

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions